Although fibroblast growth factor 21 (FGF21) and its co‐receptor, Klotho, are implicated in mediating DPR benefits, diet‐induced obesity by HF appears to blunt their response (Figure 1H). Here, FGF21 is linked to obesity due to melanocortin 4 receptor deficiency.